PharmaCorp Completes Acquisition of Pharmacy Files in Western Canada

• PharmaCorp Rx Inc. completed the acquisition of pharmacy files, patient records, and operational data in Western Canada for a purchase price of $300,000.
• The transaction was funded entirely with cash on hand; no external financing or finder's fees were required.
• Assets will be integrated into an existing PharmaChoice-bannered pharmacy to enhance operational efficiency and continuity of care.
• This follows a non-binding Letter of Intent (LOI) announced in December 2025 for approximately $350,000.
• The acquisition excludes the target's corporate entity, fixtures, or other operating assets.

• Materiality: Low to Moderate. While positive for execution, the $300,000 purchase price is negligible relative to Fiscal Year 2025 revenue of $20.9 million and cash position of $25.9 million.
• Expectations: The deal was anticipated following the December 2025 LOI; therefore, it does not contain unexpected market-moving information.
• Context: This news is overshadowed by the April 30, 2026 announcement to acquire eight pharmacies for $24.2 million. The May 1 filing confirms smaller pipeline progress but does not alter the primary growth thesis established yesterday.
• Financial Impact: Minimal immediate impact on revenue or earnings; primarily operational integration benefit.

• Business Model: Retail pharmacy operator under the PharmaChoice Canada banner, focusing on national consolidation through M&A.
• Flagship Project: Expansion of the pharmacy network across Western and Eastern Canada via acquisition of independent pharmacies and pharmacy files.
• Growth Strategy: Acquiring existing locations to scale revenue quickly while maintaining local management continuity.
• Operational Focus: Integration of patient records and operational data to improve efficiency without disrupting care continuity.